Cited by 198Cytokine Signaling Pathways and InteractionsBlood disorders and treatmentsChemokine receptors and signaling

STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils

Open access
Panopoulos, A. D., Zhang, L., Snow, J. W., Jones, D. M., Smith, A. M., El Kasmi, K. C., Liu, F., Goldsmith, M. A. +3 more·2006·Blood

Abstract

Granulocyte colony-stimulating factor (G-CSF) is essential for the host response to bacterial infection by controlling neutrophil production in the bone marrow. The G-CSF receptor (G-CSFR) activates the Jak/STAT pathway, although little is understood about how these signals regulate basal and stress-induced granulopoiesis. We examined STAT3 function in granulocytes using a bone marrow conditional knockout mouse model. Our results show that STAT3 has a crucial role in emergency granulopoiesis and mature neutrophil function. STAT3-deficient mice have an aberrant response to G-CSF in vivo, characterized by failure to accumulate immature granulocytes and an increased ratio of mature to immature neutrophils in the bone marrow, peripheral blood, and spleen. Acute neutrophil mobilization is impaired in STAT3-deficient mice as judged by their failure to up-regulate circulating neutrophils following short-term G-CSF exposure. STAT3 also controls neutrophil chemotactic responses to natural ligands for CXCR2 and regulates the magnitude of chemoattractant-induced actin polymerization. These functions of STAT3 are independent of its principal target gene Socs3, which encodes a crucial feedback inhibitor of cytokine signaling. Our results demonstrate the existence of distinct STAT3 target pathways in neutrophils required for granulopoiesis and innate immunity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2006-02-003012

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AD-HIES primary immune defects include intrinsic impairments in neutrophil chemotaxis.

    “intrinsic impairments in neutrophil chemotaxis”

    From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Panopoulos et al., 2006

    The Results (page not provided) show a cell-autonomous chemotaxis defect in STAT3-deficient mouse neutrophils, specifically in responses to the CXCR2 ligands MIP-2 and KC; migration toward fMLP was similar to controls. The paper does not establish that impaired neutrophil chemotaxis is a primary immune defect in people with AD-HIES. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • STAT3 activation mediates neutrophil mobilization in the bone marrow, neutrophil release into the circulation, and neutrophil chemotaxis by upregulating CXCR2/Il8rb and MIP-2/Cxcl2.

    “STAT3 activation mediates neutrophil mobilization in the bone marrow”

    From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Panopoulos et al., 2006

    The Results and Discussion support a role for STAT3 in acute G-CSF–induced neutrophil mobilization from bone marrow into circulation and in chemotaxis toward MIP-2. They do not support the quoted mechanism of upregulating CXCR2/Il8rb and MIP-2/Cxcl2: the Results explicitly state that CXCR2 expression is independent of STAT3 and describe MIP-2 as a chemoattractant used to test the response. The Discussion also cautions that STAT3 is not necessary for all neutrophil mobilization. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 44

  1. [1]Nicola NA, Metcalf D, Johnson GR, Burgess AW. Separation of functionally distinct human granulocyte-macrophage colony stimulating factors. Blood. 1979;54: 614-627. [PubMed] [Google Scholar]
  2. [2]Liu F, Wu HY, Wesselschmidt R, Kornaga T, Link DC. Impaired production and increased apoptosis of neutrophils in granulocyte colony-stimulating factor receptor-deficient mice. Immunity. 1996;5: 491-501. [DOI] [PubMed] [Google Scholar]
  3. [3]Lieschke GJ, Grail D, Hodgson G, et al. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood. 1994;84: 1737-1746. [PubMed] [Google Scholar]
  4. [4]Basu S, Hodgson G, Katz M, Dunn AR. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation. Blood. 2002;100: 854-861. [DOI] [PubMed] [Google Scholar]
  5. [5]Lord BI, Molineux G, Podja Z, Souza LM, Mermod JJ, Dexter TM. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood. 1991;77: 2154-2159. [PubMed] [Google Scholar]
  6. [6]Betsuyaku T, Liu F, Senior RM, et al. A functional granulocyte colony-stimulating factor receptor is required for normal chemoattractant-induced neutrophil activation. J Clin Invest. 1999;103: 825-832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. [7]Semerad CL, Poursine-Laurent J, Liu F, Link DC. A role for G-CSF receptor signaling in the regulation of hematopoietic cell function but not lineage commitment or differentiation. Immunity. 1999;11: 153-161. [DOI] [PubMed] [Google Scholar]
  8. [8]O'Shea JJ, Gadina M, Schreiber RD. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 2002;109: S121-S131. [DOI] [PubMed] [Google Scholar]
  9. [9]Snow JW, Abraham N, Ma MC, Abbey NW, Herndier B, Goldsmith MA. STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells. Blood. 2002;99: 95-101. [DOI] [PubMed] [Google Scholar]
  10. [10]Moriggl R, Sexl V, Kenner L, et al. Stat5 tetramer formation is associated with leukemogenesis. Cancer Cell. 2005;7: 87-99. [DOI] [PubMed] [Google Scholar]
  11. [11]Bunting KD, Bradley HL, Hawley TS, Moriggl R, Sorrentino BP, Ihle JN. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5. Blood. 2002;99: 479-487. [DOI] [PubMed] [Google Scholar]
  12. [12]Teglund S, McKay C, Schuetz E, et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 1998;93: 841-850. [DOI] [PubMed] [Google Scholar]
  13. [13]Durbin JE, Hackenmiller R, Simon MC, Levy DE. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell. 1996;84: 443-450. [DOI] [PubMed] [Google Scholar]
  14. [14]Meraz MA, White JM, Sheehan KC, et al. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell. 1996;84: 431-442. [DOI] [PubMed] [Google Scholar]
  15. [15]Lee CK, Raz R, Gimeno R, et al. STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity. 2002;17: 63-72. [DOI] [PubMed] [Google Scholar]
  16. [17]Kamezaki K, Shimoda K, Numata A, et al. Roles of Stat3 and ERK in G-CSF signaling. Stem Cells. 2005;23: 252-263. [DOI] [PubMed] [Google Scholar]
  17. [18]Croker BA, Metcalf D, Robb L, et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity. 2004;20: 153-165. [DOI] [PubMed] [Google Scholar]
  18. [19]McLemore ML, Grewal S, Liu F, et al. STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity. 2001;14: 193-204. [DOI] [PubMed] [Google Scholar]
  19. [20]Hermans MH, Antonissen C, Ward AC, Mayen AE, Ploemacher RE, Touw IP. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med. 1999;189: 683-692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. [21]van de Geijn GJ, Gits J, Aarts LHJ, Heijmans-Antonissen C, Touw IP. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood. 2004;104: 667-674. [DOI] [PubMed] [Google Scholar]
  21. [22]Panopoulos AP, Bartos D, Zhang L, Watowich SS. Control of myeloid-specific integrin αMβ2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1. J Biol Chem. 2002;277: 19001-19007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. [23]Shimozaki K, Nakajima K, Hirano T, Nagata S. Involvement of STAT3 in the granulocyte colony-stimulating factor-induced differentiation of myeloid cells. J Biol Chem. 1997;272: 25184-25189. [DOI] [PubMed] [Google Scholar]
  23. [24]Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. 2001;193: 741-754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. [25]Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto T, Akira S. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol. 1998;161: 4652-4660. [PubMed] [Google Scholar]
  25. [26]Takeda K, Clausen BE, Kaisho T, et al. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 1999;10: 39-49. [DOI] [PubMed] [Google Scholar]
  26. [27]Croker BA, Krebs DL, Zhang JG, et al. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol. 2003;4: 540-545. [DOI] [PubMed] [Google Scholar]
  27. [28]Lang R, Rutschman RL, Greaves DR, Murray PJ. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J Immunol. 2002;168: 3402-3411. [DOI] [PubMed] [Google Scholar]
  28. [29]Lang R, Patel D, Morris JJ, Rutschman RL, Murray PJ. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol. 2002;169: 2253-2263. [DOI] [PubMed] [Google Scholar]
  29. [30]Chervenick PA, Boggs DR, Marsh JC, Cartwright GE, Wintrobe MM. Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol. 1968;215: 353-360. [DOI] [PubMed] [Google Scholar]
  30. [32]Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity. 2002;17: 413-423. [DOI] [PubMed] [Google Scholar]
  31. [33]Wooten DK, Xie X, Bartos D, Busche RA, Longmore GD, Watowich SS. Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. J Biol Chem. 2000;275: 26566-26575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. [34]Kim CH, Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 1998;91: 100-110. [PubMed] [Google Scholar]
  33. [35]Hestdal K, Ruscetti FW, Ihle JN, et al. Characterization and regulation of RB6–8C5 antigen expression on murine bone marrow cells. J Immunol. 1991;147: 22-28. [PubMed] [Google Scholar]
  34. [36]Tamura M, Hattori K, Nomura H, Oheda M, Kubota N. Induction of neutrophilic granulocytosis in mice by administration of purified human native granulocyte colony-stimulating factor (G-CSF). Biochem Biophys Res Commun. 1987;142: 454-460. [DOI] [PubMed] [Google Scholar]
  35. [37]Roberts AW, Metcalf D. Granulocyte colony-stimulating factor induces selective elevations of progenitor cells in the peripheral blood of mice. Exp Hematol. 1994;22: 1156-1163. [PubMed] [Google Scholar]
  36. [38]Lee J, Cacalano G, Camerato T, Toy K, Moore MW, Wood WI. Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol. 1995;155: 2158-2164. [PubMed] [Google Scholar]
  37. [39]Bozic CR, Gerard NP, von Uexkull-Guldenband C, et al. The murine interleukin 8 type B receptor homologue and its ligands: expression and biological characterization. J Biol Chem. 1994;269: 29355-29358. [PubMed] [Google Scholar]
  38. [40]Boulay R, Tardif M, Brouchon L, Vignais P. The human N-formylpeptide receptor: characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry. 1990;29: 11123-11133. [DOI] [PubMed] [Google Scholar]
  39. [41]Gao J-L, Lee EJ, Murphy PM. Impaired anitbacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med. 1999;189: 657-662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. [42]Weiner OD, Servant G, Welch MD, Mitchison TJ, Sedat JW, Bourne HR. Spatial control of actin polymerization during neutrophil chemotaxis. Nat Cell Biol. 1999;1: 75-81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. [43]Turkson J. STAT proteins as novel targets for cancer drug discovery. Expert Opin Ther Targets. 2004;8: 409-422. [DOI] [PubMed] [Google Scholar]
  42. [44]Burdon PC, Martin C, Rankin SM. The CXC chemokine MIP-2 stimulates neutrophil mobilization from the rat bone marrow in a CD49d-dependent manner. Blood. 2005;105: 2543-2548. [DOI] [PubMed] [Google Scholar]
  43. [46]Silver DL, Naora H, Liu J, Cheng W, Montell DJ. Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility. Cancer Res. 2004;64: 3550-3558. [DOI] [PubMed] [Google Scholar]
  44. [47]Sano S, Itami S, Takeda K, et al. Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 1999;18: 4657-4668. [DOI] [PMC free article] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Panopoulos, A. D., Zhang, L., Snow, J. W., Jones, D. M., Smith, A. M., El Kasmi, K. C., Liu, F., Goldsmith, M. A., Link, D. C., Murray, P. J., & Watowich, S. S.
Affiliations
Boston Children's Hospital (US)
Venue
Blood
Published
2006-12-01
Volume
108
Issue
12
Pages
3682-3690
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2030726748
Cited by
198
References
2
Citations by year
2026: 6 · 2025: 10 · 2024: 6 · 2023: 11 · 2022: 9 · 2021: 11 · 2020: 8 · 2019: 11 · 2018: 11 · 2017: 13 · 2016: 10 · 2015: 6 · 2014: 10 · 2013: 13 · 2012: 7
FWCI
6.09
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA077447, T32CA009598, CA77447, T32 CA09598-16)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Blood disorders and treatments
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords
STAT3, emergency granulopoiesis, neutrophils, granulocyte colony-stimulating factor, G-CSF receptor, JAK/STAT signaling, neutrophil mobilization, neutrophil chemotaxis, CXCR2, actin polymerization, SOCS3, innate immunity, bone marrow
MeSH terms
Suppressor of Cytokine Signaling 3 Protein, Animals, Bacterial Infections, Bone Marrow, Cell Differentiation, Chemotaxis, Immunity, Innate, Neutrophils, Signal Transduction, Granulocyte Colony-Stimulating Factor, Receptors, Granulocyte Colony-Stimulating Factor, Mice, Knockout, Myelopoiesis, STAT3 Transcription Factor, Suppressor of Cytokine Signaling Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review